Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Enrollment

Disease Outbreaks

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Cuban Authorities Work To Contain Cholera Outbreak In Capital City

“Cuban authorities are scrambling to contain a cholera outbreak that has sickened dozens of people in Havana, the capital city of 2.2 million residents and a popular tourism destination,” Reuters reports (Frank, 1/15). The country’s “second cholera outbreak in four months — after 130 years without the disease — has sickened more…

WHO Recommends Vaccine Makers Move Forward In Mass Production Of H1N1 Vaccine

“Saying the new H1N1 [swine flu] virus is ‘unstoppable’, the WHO gave drug makers a full go-ahead to manufacture vaccines against the pandemic influenza strain on Monday and said healthcare workers should be the first to get one,” Reuters reports (Fox, 7/14). This, as “Britain, Brazil, Colombia, Mexico, the Philippines…

U.S. To Commit Additional $1B To H1N1 Vaccine Development

HHS Secretary Kathleen Sebelius said Sunday the U.S. has agreed to put an addition $1 billion towards ingredients for the production of a vaccine that offers protection against the H1N1 (swine flu) virus, Reuters reports.

WHO Stops Tracking H1N1 Cases

“In a move that caught many public health experts by surprise, the WHO quietly announced Thursday that it would stop tracking swine flu cases and deaths around the world,” the New York Times reports.

Countries Ramp Up H1N1 Preparedness

The following articles look at how countries are combating H1N1 (swine flu): NPR’s Morning Edition examines the “complicated” task ahead to administer two vaccines – one that offers protection against the seasonal flu, the other protecting against the H1N1 (swine flu) virus – to the public this fall (Knox, 7/20).…

Global Health Officials Working To Prevent H1N1 Spread

“Global health officials are scrambling to try to prevent the spread of the H1N1 swine flu virus, with U.S. officials moving Thursday with a recommendation that the Food and Drug Administration approve or license a [new H1N1] vaccine,” without waiting on the results from “clinical trials to test its safety and efficacy,” Wall Street Journal reports (Dooren/Winning, 7/24).